MedPath

BAYER HEALTHCARE PHARMACEUTICALS

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Enzalutamide and Radium-223 Combo Improves Survival in Metastatic Prostate Cancer

The combination of enzalutamide and radium-223 significantly improved overall survival in men with castration-resistant prostate cancer and bone metastases.

© Copyright 2025. All Rights Reserved by MedPath